Johannes Czernin, MD

Dr. Johannes Czernin and his colleagues are studying the metabolic phenotype of tumor tissue and its relationship to the genotype.

The focus of Czernin's research is to refine the clinical role of molecular PET imaging. He has adopted a translational research approach by which radioactive ligand uptake in cell cultures determines the use of specific molecular imaging probes in small animals and later on in humans.